Canada’s largest publicly traded producer of medical marijuana is making the case for the quality of weed made by large-scale manufacturers compared to homegrown bud.
Canada’s biggest drugstore chain is exploring the possibility of getting into medical-marijuana sales in a move that would dramatically alter the landscape of the new industry